Long-term safety data on Lialda published in leading ... (ment-related AEs were experienced by a t...)

Long-term safety data on Lialda published in leading GI journal

Date:6/17/2008

ment-related AEs were experienced by a total of 10.2 percent of patients [11.1 percent of patients (n=225) in the once-daily group and 9.4 percent of patients (n=234) in the twice-daily group]. A total of 3.9 percent of patients experienced serious AEs [4 percent of patients (n=225) in the once-daily group and 3.8 percent of patients (n=234) in the twice-daily group], most of which were gastrointestinal disorders, and only one serious AE was considered to be related to study treatment.

The secondary endpoints of the study evaluated maintenance of remission and relapse rates over 12 months. In the efficacy population at entry (month 0), 78.1 percent of patients (n=219) in the once-daily group and 82.3 percent of patients (n=232) in the twice-daily group were in clinical and endoscopic remission. At month 12, 64.4 percent of patients in the once-daily and 68.5 percent of patients in the twice-daily group were in strictly defined clinical and endoscopic remission (P=0.351). Thus, there was no significant difference between the once-daily and twice-daily groups with respect to strictly defined clinical and endoscopic remission at month 12. Further, 88.9 percent and 93.2 percent of patients in each group, respectively, had maintained clinical remission and were considered "relapse-free".

Study Background

A total of 459 patients were enrolled and randomized in the 303 long-term safety study (246 directly from the parent studies 301 and 302 - Lialda's eight-week, Phase III, placebo-controlled trials that demonstrated efficacy for the induction of remission in active, mild to moderate UC - and 213 patients who received an additional 8 weeks of treatment with Lialda 4.8 g/day to induce remission). Remission was defined using stringent clinical and endoscopic measures: modified UC Disease Activity Index (UC-DAI) score of ≤1, with scores of 0 for rectal bleeding and stool frequency, and a combined Physician's Global Assessment and sigmoidos
'/>"/>

Contact: Blythe Bertolo
bbertolo@golinharris.com
312-729-4463
Shire plc
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
2. Some patients may not need insulin for long-term control of type 2 diabetes
3. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
4. Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Wont Cover It
5. Treatment at an AASM accredited sleep center improves long-term CPAP compliance
6. Poor sleep a problem in long-term breast cancer survivors
7. Long-term pesticide exposure may increase risk of diabetes
8. Long-term bouts with hay fever worsen ability to breathe through your nose
9. Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company
10. Long-term hormone replacement therapy increases breast cancer risk
11. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants

Post Your Comments:

(Date:12/16/2009)... to disease , , WEDNESDAY, Dec. 16 (HealthDay News) ... leprosy have been identified by scientists in Singapore ... than 10,000 DNA samples from leprosy patients and ... the important role that the innate immune response ... leprosy is not common, the discoveries have significant ...

(Date:12/16/2009)... could help ease health and environmental concerns about the ... for changing the behavior of nanoparticles in municipal sewage ... Their study was published in ACS, journal Environmental ... UK Centre for Ecology and Hydrology and colleagues note ... nanoparticles particles less than 1/1000th the width of ...

(Date:12/16/2009)... Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging at an Affordable ... ... Angeles, CA (PRWEB) December 16, 2009 -- Actively healthy families ... all natural skin care for their children as Episencial ... featuring the beloved artwork of The Very Hungry Caterpillar from ...

(Date:12/16/2009)... caution, though, that no direct link has been found, ... bacteria in food -- commonly linked to food poisoning ... might also be the cause of some urinary tract ... the bacteria in chicken from stores and restaurants and ... evidence that the germs were transmitted directly to the ...

(Date:12/16/2009)... and MassBio promote Massachusetts companies through annual marketing campaign ... ... 2009 -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , , ,Genetown is sponsored by MassBio ... device industries. The campaign places each entity’s brand on an ...

Breaking Medicine News(10 mins):Health News:Leprosy Genes Identified 2 Health News:Behavior modification could ease concerns about nanoparticles 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3 Health News:Thriving Bioscience Region Leaves Its Mark 2

[0] Leprosy Genes Identified [0] Behavior modification could ease concerns about nanoparticles [1] New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" [0] Foodborne E. Coli Suspected in Urinary Tract Infections [0] Thriving Bioscience Region Leaves Its Mark

... CHAPEL HILL, N.C., Sept. 13 "Profit, customers and,people ... the conference,Human Capital Management: Facing the Challenges of the ... taking care of your people, your people,will take care ... of your,business." At the recent HR-focused conference of ...

... now under development could enhance the design of sports ... sporting potential. , The models, more sophisticated and more ... produce unprecedentedly realistic simulations of how potential ball designs, ... , This data can then be harnessed by sports ...

... N.J., Sept. 12 The following is,a statement issued by ... CASSIDY, ON BEHALF OF ROSA ACUNA, RE: ... V. TURKISH, Today,s opinion is a stunning and surprising, ... Jersey. The opinion represents a,significant departure, in our judgment, from ...

... /PRNewswire-FirstCall/ - Transition Therapeutics Inc.,("Transition" or the ... developing therapeutics for disease indications,with large markets, ... year,ended June 30, 2007. Selected Highlights ... up to the date of this press ...

... EPI-Q, a leading healthcare,management consulting firm, announces today ... key appointment. EPI-Q, Inc. specializes in assisting life,sciences ... outcomes,and cost-effectiveness of patient care. Andrew Baker ... NY. Mr. Baker will have responsibility for global ...

... BEDFORD, Mass., Sept. 12 Hologic, ... of state-of-the-art diagnostic and,digital imaging systems directed ... statement, including a joint proxy,statement/prospectus, for a ... ), has become effective. The Company will ...

Broker a Suite of Research & Advisory Services to Enhance Human Resources Computer models help raise the bar for sporting achievement Historic Abortion Case; Acuna V. Turkish Transition Therapeutics Announces Fiscal 2007 Year End Financial Results EPI-Q Opens East Coast Office and Appoints Vice President-Business Development Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation

(Date:12/16/2009)... NASHVILLE, Tenn. , Dec. 16 ... medical cost management services, today commended two new ... from CT scans and other diagnostic imaging tests. ... essential to proper diagnosis and treatment," said Gregg ... these new studies offer more compelling evidence that ...

(Date:12/16/2009)... -- Wound Management Technologies, Inc. (OTC Bulletin ... specialty medical products, announced today that its ... productization of its patented orthopedic bone void ... to be introduced in Q3 2010, to ... multi-billion dollar international market. ,, "Resorbable Orthopedics ...

(Date:12/16/2009)... A new application developed ... clinical review of specialty pharmaceuticals has increased health ... reviewed while reducing costs. ,, AIM, a leading ... health plan clients representing over 35 million consumers ... WLP ), adapted the successful clinical ...

Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2 MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4 NCR Embeds DigitalPersona U are U 28R 29 4500HD Fingerprint Sensor in New NCR RealPOS 28TM 29 70XRT Point of Sale Workstations 10017 1 NCR Embeds DigitalPersona U are U 28R 29 4500HD Fingerprint Sensor in New NCR RealPOS 28TM 29 70XRT Point of Sale Workstations 10017 2 45 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 1 45 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 2 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 1 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 2 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 3 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 4

[0] MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure [0] Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics [0] American Imaging Management's New Specialty Drug Program Delivers Immediate Results

... Diabetes Therapy Also Improved Glucose ... Day, SAN FRANCISCO, June 9 Amylin Pharmaceuticals,Inc. ... LLY ), and Alkermes, Inc.,(Nasdaq: ALKS ) ... showed the durable efficacy of exenatide once weekly, a,long-acting ...

... long-term, large-scale and,independent studies evaluating cardiovascular (CV) outcomes ... 9,300 patients taking AVANDIA(R),(rosiglitazone maleate) and provide more ... The Veterans Affairs Diabetes Trial,(VADT), through two separate ... is no evidence to suggest that use of ...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)

The TBR-360-1-GD is a large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standar...

... precise requirements of blood banking and ... Equipment meets American Association of Blood ... (ANRC) and U.S. Food & Drug ... and platelet incubators feature alarm systems ...

Refrigerator specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997....

TBR-120-1-GD is large capacity upright style refrigerator with an operating temperature of +4C. It is a specially designed refrigerator for the storage of blood in standard 500ml bags, complying with...

Medicine Products:

Blood Storage Refrigerator TBR-360-1-GD Blood Bank Refrigerator 3626 Blood Storage Refrigerator TBR-160-1-GD Blood Storage Refrigerator TBR-120-1-GD

Long-term safety data on Lialda published in leading ...(ment-related AEs were experienced by a t...),Health